SUMMARY A 28-year-old woman presenting with subacute onset of a tetraplegia is described who was shown to have active systemic lupus erythematosus in association with high circulating anticardiolipin binding and lupus anticoagulant activity. The patient later developed severe symptomatic systemic and pulmonary hypertension and required emergency resuscitation. This case provides further support for an association between antiphospholipid antibodies and the clinical features of central nervous system (CNS) involvement and pulmonary hypertension in SLE.
Involvement of the central nervous system in systemic lupus erythematosus (SLE) may be a major problem in terms of management and prognosis, though it is very seldom a presenting feature of the condition. An association has been described between the 'lupus anticoagulant', circulating antibodies directed against phospholipid antigens, particularly cardiolipin, and recurrent arterial and venous thromboses including cerebral thromboses.'
In view of the recent report of a further possible association of lupus anticoagulant activity and pulmonary hypertension2 we describe a patient who presented with a tetraplegia and was found to have active SLE with high anticardiolipin binding and lupus anticoagulant activity, who developed pulmonary hypertension. 6 . Diagnoses were made of 'functional' tricuspid and mitral regurgitation secondary to increased vascular resistance.
The hypertension was subsequently well controlled with nifedipine, though proteinuria had increased to 6-5 g/day, and azathioprine was added to the steroid therapy. There has been no significant recovery of the neurological deficit three months after its onset.
Discussion
Neuropsychiatric manifestations of systemic lupus are common, reported in 37%4 and 59%5 of two large series. The commonest features are psychiatric illness and seizures, but about 10% of patients may have evidence of pyramidal tract lesions (usually attributed to a 'cerebrovascular accident'), and rare cases of transverse myelopathy have been described.6 7 However, neurological presentation is very rare.8 In one series5 3% of patients with SLE presented with seizures, but all other neuropsychiatric features developed later in the course of their disease. Fulford et al.9 reported five women with slowly progressive spastic paraplegia resembling multiple sclerosis, in whom weakly positive autonuclear antibodies were detected. They proposed the term 'lupoid sclerosis' and also reviewed the few other published accounts of SLE patients with neurological disturbance at presentation.
In our patient the first manifestation of SLE may have been the initial left hemiparesis in 1978, and by 1980 bilateral pyramidal tract lesions were present without any evidence of haemorrhage or infarct on computerised tomography (CT) of the brain. A spastic tetraplegia of subacute onset later developed with unequivocal active SLE, as shown by the accompanying positive ANA, strongly positive anti-DNA antibodies, proteinuria, and thrombocytopenia. The CSF protein concentration was also raised, though cervical myelography and repeat CT brain scan failed to show a structural lesion.
The pathogenesis of cerebral and spinal cord lesions is uncertain and probably multifactorial. 
